Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes

NCT03625518 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT03625518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03625518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2018
Completion date
January 31, 2021
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, induction of labor affected fetus / newborn